Cresco Labs Inc (CRLBF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 74,811 | 90,452 | 121,510 | 132,320 | 92,334 |
| Receivables | 59,099 | 50,060 | 56,939 | 51,649 | 44,592 |
| Inventories | 120,861 | 134,881 | 134,608 | 152,591 | 158,912 |
| Other current assets | 2,862 | 3,213 | 3,569 | 18,641 | 18,479 |
| TOTAL | $265,244 | $286,320 | $326,046 | $355,201 | $314,317 |
| Non-Current Assets | |||||
| PPE Net | 388,276 | 390,583 | 379,722 | 377,941 | 396,168 |
| Investments And Advances | 931 | 1,191 | 1,228 | 1,670 | 1,992 |
| Intangibles | 712,850 | 736,650 | 738,145 | 879,822 | 881,721 |
| Other Non-Current Assets | 143,930 | 135,813 | 138,551 | 141,657 | 106,845 |
| TOTAL | $1,245,987 | $1,264,237 | $1,257,646 | $1,401,090 | $1,386,726 |
| Total Assets | $1,511,231 | $1,550,557 | $1,583,692 | $1,756,291 | $1,701,043 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 18,293 | 28,112 | 10,976 | 28,847 | 19,357 |
| Accounts payable and accrued liabilities | 20,393 | 20,134 | 28,093 | 29,194 | 36,988 |
| Accrued Expenses | 78,032 | 76,499 | 65,161 | 58,589 | 45,933 |
| TOTAL | $237,646 | $272,549 | $255,865 | $270,560 | $228,216 |
| Non-Current Liabilities | |||||
| Long Term Debt | 471,553 | 470,895 | 476,891 | 468,064 | 467,082 |
| Deferred Revenues | 2,108 | 41,046 | 47,834 | 50,066 | 44,796 |
| aiOther Non-Current Liabilities | 30,339 | 8,761 | 26,286 | 461 | 1,763 |
| TOTAL | $726,605 | $710,633 | $740,144 | $714,284 | $689,203 |
| Total Liabilities | $964,251 | $983,182 | $996,009 | $984,844 | $917,419 |
| Shareholders' Equity | |||||
| Common Shares | 1,778,505 | 1,728,356 | 1,617,093 | 1,704,809 | 1,700,008 |
| Retained earnings | -1,153,973 | -1,105,551 | -1,076,198 | -915,258 | -900,031 |
| Other shareholders' equity | -77,552 | -55,430 | -40,749 | -18,104 | -16,353 |
| TOTAL | $546,980 | $567,375 | $587,683 | $771,447 | $783,624 |
| Total Liabilities And Equity | $1,511,231 | $1,550,557 | $1,583,692 | $1,756,291 | $1,701,043 |